Twist Bioscience Corp vs Valero Energy Corporation — how do they compare? Twist Bioscience Corp trades at $155.76 (market cap $10.08B), while Valero Energy Corporation trades at $441.5 (market cap $127.78B). The key difference: Valero Energy Corporation is far larger — about 12.7× Twist Bioscience Corp's market cap, and Valero Energy Corporation pays a 1.08% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and Valero Energy Corporation for 56 Days on average.
| TWST | VLO | |
|---|---|---|
Market Cap | $10.08B | $127.78B |
Volume | 4,229,037 | 2,570,225 |
Sector | Health | Energy |
52-Week High | $205.00 | $443.80 |
52-Week Low | $25.45 | $156.39 |
Typical Hold Time | 27 Days | 56 Days |
Enterprise Value | $10.01B | $131.26B |
Dividend Yield | — | 1.08% |
Signals from Pluang's Aura AI — not financial advice
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
Valero Energy (VLO) trades at $424.10, up 1.16% with strong technical momentum and bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $176.4B in 2022 to $122.7B in 2025. Analyst consensus remains positive with 57% buy ratings, though the current price exceeds the $408.10 consensus target. Recent news highlights refining sector strength and institutional buying interest.
VLO presents a mixed outlook with strong operational performance offset by revenue pressures. The stock's premium valuation (P/E 17.69) and overbought RSI suggest near-term caution, but projected 2026 earnings growth ($7.2B net income) and dividend yield provide support. Key risks include refining margin volatility and potential policy impacts from diesel export restrictions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →